Meet us in Boston!

May 16, 2025 | Unclassified

We believe better drugs start with better translational models! Curious to know more about how we combine complex patient-based cellular disease models with AI-enhanced high-throughput phenotypic screening to identify targets and drug candidates with increased predictivity for clinical development? I would be happy to meet in Boston and discuss how our skills could enrich your R&D efforts.

Share This